Ticker Scorecard - VCEL Basics Company: Vericel Corporation IPO Date: November 25, 2014 Sector: Healthcare Industry: Biotech Activated in VL: True Average Daily Range Avg Daily Range: $0.54 | 2.55% Avg Daily Range (30 D): $1.16 | 2.00% Avg Daily Range (90 D): $1.01 | 1.88% Institutional Daily Volume Avg Daily Volume: .45M Avg Daily Volume (30 D): .32M Avg Daily Volume (90 D): .3M Trade Size Avg Trade Size (Sh.): 106 Avg Trade Size (Sh.) (30 D): 45 Avg Trade Size (Sh.) (90 D): 44 Institutional Trades Total Inst.Trades: 2,592 Avg Inst. Trade: $2.53M Avg Inst. Trade (30 D): $2.23M Avg Inst. Trade (90 D): $2.18M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.9M Avg Closing Trade (30 D): $3.23M Avg Closing Trade (90 D): $3.43M Avg Closing Volume: 90.2K     News Aug 1, 2024 @ 11:55 AM Vericel Reports Second Quarter 2024 Financial Resu... Source: Vericel Corporation Jul 30, 2024 @ 6:00 AM Global Regenerative Medicine Market Size To Worth ... Source: Spherical Insights & Consulting Jul 18, 2024 @ 9:02 PM Vericel corp chief legal officer sells $782,700 in... Source: Investing.Com Jun 11, 2024 @ 12:30 PM Vericel to Present at the Truist Securities MedTec... Source: Vericel Corporation May 22, 2024 @ 12:30 PM Vericel to Present at the Leerink Partners Healthc... Source: Vericel Corporation Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.02 $-.1 $-.08 Diluted EPS $-.02 $-.1 $-.08 Revenue $ 57.91M $ 52.66M $ 51.28M Gross Profit $ 41.65M $ 36.6M $ 35.35M Net Income / Loss $ -.9M $ -4.68M $ -3.86M Operating Income / Loss $ -2.47M $ -6.03M $ -5.46M Cost of Revenue $ 16.25M $ 16.06M $ 15.93M Net Cash Flow $ -5.5M $ 5.11M $ -16.12M PE Ratio     Splits Oct 16, 2013:   20:1 Feb 18, 2010:   8:1